208 related articles for article (PubMed ID: 19837911)
1. N-terminal propeptide of type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone.
Bhasin S; He EJ; Kawakubo M; Schroeder ET; Yarasheski K; Opiteck GJ; Reicin A; Chen F; Lam R; Tsou JA; Castaneda-Sceppa C; Binder EF; Azen SP; Sattler FR
J Clin Endocrinol Metab; 2009 Nov; 94(11):4224-33. PubMed ID: 19837911
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
Blackman MR; Sorkin JD; Münzer T; Bellantoni MF; Busby-Whitehead J; Stevens TE; Jayme J; O'Connor KG; Christmas C; Tobin JD; Stewart KJ; Cottrell E; St Clair C; Pabst KM; Harman SM
JAMA; 2002 Nov; 288(18):2282-92. PubMed ID: 12425705
[TBL] [Abstract][Full Text] [Related]
3. Bone alkaline phosphatase and collagen markers as early predictors of height velocity response to growth-promoting treatments in short normal children.
Crofton PM; Stirling HF; Schönau E; Kelnar CJ
Clin Endocrinol (Oxf); 1996 Apr; 44(4):385-94. PubMed ID: 8706304
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of muscle quality: N-terminal propeptide of type III procollagen and C-terminal agrin fragment responses to resistance exercise training in older adults.
Fragala MS; Jajtner AR; Beyer KS; Townsend JR; Emerson NS; Scanlon TC; Oliveira LP; Hoffman JR; Stout JR
J Cachexia Sarcopenia Muscle; 2014 Jun; 5(2):139-48. PubMed ID: 24197815
[TBL] [Abstract][Full Text] [Related]
5. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
Gürlek A; Gedik O
J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
[TBL] [Abstract][Full Text] [Related]
6. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
[TBL] [Abstract][Full Text] [Related]
7. Association between plasma procollagen type III N-terminal peptide (P3NP) levels and physical performance in elderly men: The Korean Frailty and Aging Cohort Study (KFACS).
Shin HE; Kim M; Won CW
Exp Gerontol; 2021 Oct; 154():111523. PubMed ID: 34425203
[TBL] [Abstract][Full Text] [Related]
8. Testosterone and growth hormone improve body composition and muscle performance in older men.
Sattler FR; Castaneda-Sceppa C; Binder EF; Schroeder ET; Wang Y; Bhasin S; Kawakubo M; Stewart Y; Yarasheski KE; Ulloor J; Colletti P; Roubenoff R; Azen SP
J Clin Endocrinol Metab; 2009 Jun; 94(6):1991-2001. PubMed ID: 19293261
[TBL] [Abstract][Full Text] [Related]
9. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
[TBL] [Abstract][Full Text] [Related]
10. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human growth hormone and recombinant human insulin-like growth factor I diminish the catabolic effects of hypogonadism in man: metabolic and molecular effects.
Hayes VY; Urban RJ; Jiang J; Marcell TJ; Helgeson K; Mauras N
J Clin Endocrinol Metab; 2001 May; 86(5):2211-9. PubMed ID: 11344229
[TBL] [Abstract][Full Text] [Related]
12. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment of osteoporotic postmenopausal women - a one-year placebo-controlled study.
Sääf M; Hilding A; Thorën M; Troell S; Hall K
Eur J Endocrinol; 1999 May; 140(5):390-9. PubMed ID: 10229902
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of growth hormone abuse biomarkers and the influence of gender and testosterone: a randomized double-blind placebo-controlled study in young recreational athletes.
Nelson AE; Meinhardt U; Hansen JL; Walker IH; Stone G; Howe CJ; Leung KC; Seibel MJ; Baxter RC; Handelsman DJ; Kazlauskas R; Ho KK
J Clin Endocrinol Metab; 2008 Jun; 93(6):2213-22. PubMed ID: 18381573
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of collagen synthesis and linear growth by growth hormone in glucocorticoid-treated children.
Allen DB; Goldberg BD
Pediatrics; 1992 Mar; 89(3):416-21. PubMed ID: 1741214
[TBL] [Abstract][Full Text] [Related]
17. Effects of 42 months of GH treatment on bone mineral density and bone turnover in GH-deficient adults.
Välimäki MJ; Salmela PI; Salmi J; Viikari J; Kataja M; Turunen H; Soppi E
Eur J Endocrinol; 1999 Jun; 140(6):545-54. PubMed ID: 10377504
[TBL] [Abstract][Full Text] [Related]
18. Circulating Procollagen Type III N-Terminal Peptide and Physical Function in Adults from the Long Life Family Study.
Santanasto AJ; Cvejkus RK; Wojczynski MK; Marron MM; Schupf N; Christensen K; Thyagarajan B; Zmuda JM
J Gerontol A Biol Sci Med Sci; 2021 Jun; 76(7):1273-1279. PubMed ID: 32794566
[TBL] [Abstract][Full Text] [Related]
19. Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study.
Berry SD; Ramachandran VS; Cawthon PM; Gona P; McLean RR; Cupples LA; Kiel DP
J Frailty Aging; 2013; 2(3):129-34. PubMed ID: 24244927
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human growth hormone in anorexia nervosa: a randomized, placebo-controlled study.
Fazeli PK; Lawson EA; Prabhakaran R; Miller KK; Donoho DA; Clemmons DR; Herzog DB; Misra M; Klibanski A
J Clin Endocrinol Metab; 2010 Nov; 95(11):4889-97. PubMed ID: 20668047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
